Literature DB >> 6117468

Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.

M Laakso, P J Pentikäinen, K Pyörälä, P J Neuvonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117468     DOI: 10.1093/oxfordjournals.eurheartj.a061216

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  9 in total

1.  The role of concentration--effect relationships in the QTc interval prolongation: case sotalol.

Authors:  Pertti J Neuvonen; Erkki Elonen
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

2.  Effects of bepridil on ventricular depolarization and repolarization of rabbit isolated hearts with particular reference to its possible proarrhythmic properties.

Authors:  T Osaka; I Kodama; J Toyama; K Yamada
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

3.  Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.

Authors:  R Krapf; M Gertsch
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

4.  The prolonged QT interval--a frequently unrecognized abnormality.

Authors:  R A Kenny; R Sutton
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

Review 5.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 6.  Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors:  E W Leatham; D W Holt; W J McKenna
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

Review 7.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 8.  Drug-induced torsade de pointes. Incidence, management and prevention.

Authors:  T S Faber; M Zehender; H Just
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

9.  A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.

Authors:  G D Johnston; M B Finch; J A McNeill; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.